X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1453) 1453
index medicus (1430) 1430
male (900) 900
colitis - chemically induced (898) 898
trinitrobenzenesulfonic acid (800) 800
rats (780) 780
mice (685) 685
disease models, animal (628) 628
colitis (603) 603
inflammatory-bowel-disease (505) 505
colitis - pathology (492) 492
inflammatory bowel disease (433) 433
colitis - drug therapy (423) 423
female (408) 408
colon - pathology (407) 407
gastroenterology & hepatology (405) 405
ulcerative-colitis (398) 398
inflammation (385) 385
rats, wistar (360) 360
crohns-disease (356) 356
colitis - metabolism (352) 352
rats, sprague-dawley (334) 334
colon - drug effects (327) 327
pharmacology & pharmacy (315) 315
trinitrobenzenesulfonic acid - toxicity (314) 314
humans (289) 289
colon - metabolism (283) 283
mice, inbred balb c (279) 279
peroxidase - metabolism (276) 276
abridged index medicus (249) 249
colon (226) 226
colitis - immunology (225) 225
expression (215) 215
rodents (204) 204
immunology (196) 196
intestinal mucosa - pathology (196) 196
mice, inbred c57bl (191) 191
analysis (173) 173
colitis - prevention & control (173) 173
model (169) 169
cytokines (168) 168
inflammatory bowel diseases (166) 166
experimental colitis (160) 160
bowel-disease (155) 155
gastrointestinal diseases (155) 155
intestinal mucosa - metabolism (151) 151
intestinal inflammation (148) 148
intestinal mucosa - drug effects (143) 143
colitis - physiopathology (142) 142
cytokines - metabolism (140) 140
trinitrobenzenesulfonic acid - pharmacology (136) 136
cells (135) 135
ulcerative colitis (135) 135
tumor necrosis factor-alpha - metabolism (130) 130
anti-inflammatory agents - pharmacology (125) 125
time factors (119) 119
inflammatory bowel-disease (114) 114
nf-kappa-b (111) 111
trinitrobenzenesulfonic acid - adverse effects (110) 110
colitis, ulcerative - chemically induced (109) 109
activation (108) 108
trinitrobenzenesulfonic acid - administration & dosage (108) 108
gastroenterology (107) 107
dose-response relationship, drug (106) 106
research (106) 106
immunohistochemistry (104) 104
tnbs (102) 102
physiology (101) 101
nf-kappa b - metabolism (100) 100
cells, cultured (99) 99
intestine (99) 99
anti-inflammatory agents - therapeutic use (97) 97
biochemistry & molecular biology (97) 97
inhibition (97) 97
mice, knockout (97) 97
crohn's disease (95) 95
rat (95) 95
colon - immunology (94) 94
tnbs-induced colitis (92) 92
gene expression (90) 90
oxidative stress (89) 89
apoptosis (88) 88
administration, oral (87) 87
medicine, research & experimental (87) 87
health aspects (86) 86
medicine & public health (86) 86
physiological aspects (86) 86
pathogenesis (85) 85
inflammatory bowel diseases - chemically induced (81) 81
colitis, ulcerative - drug therapy (80) 80
neurosciences (80) 80
tumor-necrosis-factor (80) 80
oncology (79) 79
article (78) 78
colitis - therapy (78) 78
inflammatory bowel diseases - pathology (77) 77
cell biology (76) 76
colitis - genetics (76) 76
enzyme-linked immunosorbent assay (75) 75
research article (75) 75
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1468) 1468
Chinese (13) 13
Japanese (4) 4
Russian (2) 2
French (1) 1
German (1) 1
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Molecules, ISSN 1420-3049, 06/2017, Volume 22, Issue 6, p. 904
Drugs such as mesalamine (5-ASA) are currently recommended for the treatment of inflammatory bowel disease (IBD). To reduce the frequency of their... 
Inflammatory bowel disease | Remission | Mucosal healing | Colitis | Hyaluronic acid | ACTIVATION | colitis | ANGIOGENESIS | INVOLVEMENT | CHEMISTRY, ORGANIC | INTERLEUKIN-6 | inflammatory bowel disease | hyaluronic acid | TELMISARTAN | DEGRADATION-PRODUCTS | remission | PPAR-GAMMA | EXPRESSION | CD44 | mucosal healing | TNBS-INDUCED COLITIS | Inflammatory Bowel Diseases - drug therapy | Intestinal Mucosa - metabolism | Cytokines - metabolism | Trinitrobenzenesulfonic Acid - administration & dosage | Rats | Hyaluronic Acid - pharmacology | Male | Inflammatory Bowel Diseases - metabolism | Intestinal Mucosa - drug effects | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Trinitrobenzenesulfonic Acid - adverse effects | Mesalamine - pharmacology | Animals | Protective Agents - pharmacology | Inflammatory Bowel Diseases - pathology | Cyclooxygenase 2 - metabolism | Inflammation Mediators - metabolism | Inflammatory Bowel Diseases - chemically induced | Disease Models, Animal | Intestinal Mucosa - pathology | Peroxidase - metabolism | Inflammatory bowel diseases | Wound healing | Mucosa | Medical treatment | Prostaglandin endoperoxide synthase | Injury prevention | Acids | Intestine | Ulcers | Rodents | Animal tissues | Vascular tissue | Peroxidase | Combined treatment | Colon | Cyclooxygenase-2 | Injuries | Index Medicus
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 6/2015, Volume 388, Issue 6, pp. 643 - 651
Journal Article
International Immunopharmacology, ISSN 1567-5769, 02/2013, Volume 15, Issue 2, pp. 372 - 380
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2015, Volume 197, pp. 48 - 57
Journal Article
Journal Article
Journal of Immunology, ISSN 0022-1767, 07/2017, Volume 199, Issue 2, pp. 718 - 733
GPBAR1 (TGR5 or M-BAR) is a G protein-coupled receptor for secondary bile acids that is highly expressed in monocytes/ macrophages. In this study, we aimed to... 
IMMUNITY | HOMEOSTASIS | DENDRITIC CELLS | INTEGRINS | FARNESOID X RECEPTOR | INFLAMMATION | CHEMOKINES | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | THERAPEUTIC TARGETS | MICROBIOTA | IMMUNOLOGY | Receptors, G-Protein-Coupled - metabolism | Chemokine CCL2 - immunology | Tumor Necrosis Factor-alpha - genetics | Antigens, Ly - genetics | Interleukin-1beta - genetics | Receptors, G-Protein-Coupled - agonists | T-Lymphocytes, Regulatory - immunology | Intestinal Mucosa - immunology | Colitis - chemically induced | Tumor Necrosis Factor-alpha - immunology | Colitis - immunology | Macrophages - immunology | Cell Line | Promoter Regions, Genetic | Interleukin-10 - deficiency | Interleukin-6 - genetics | Gene Expression Regulation - immunology | Trinitrobenzenesulfonic Acid - administration & dosage | Interleukin-1beta - immunology | Chemokine CCL2 - genetics | Inflammation - immunology | Macrophage Activation | Cholestanols - pharmacology | Phenotype | T-Lymphocytes, Regulatory - drug effects | Animals | Receptors, G-Protein-Coupled - deficiency | Antigens, Ly - immunology | Mucous Membrane - immunology | Interleukin-10 - genetics | Colitis - metabolism | Interleukin-6 - immunology | Macrophages - drug effects | Mice | Oxazolone - administration & dosage | Receptors, G-Protein-Coupled - genetics | Interleukin-10 - immunology | Cell Movement | Cholestanols - administration & dosage | CC chemokine receptors | Oxazolone | Animal models | Inflammatory bowel diseases | Trafficking | Mucosa | Activation | Regulatory sequences | Macrophages | Recruitment | Interleukin 6 | Genotype & phenotype | Cell activation | Intestine | Foxp3 protein | Colon | CD11b antigen | Bile acids | CCR7 protein | Lamina propria | Exposure | Cyclic AMP response element-binding protein | Gene expression | Ablation | CD4 antigen | Inflammatory bowel disease | White blood cells | Monocytes | Acids | Tumor necrosis factor | γ-Interferon | Interleukin 10 | Interferon | Colitis | Monocyte chemoattractant protein 1 | Bile | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2013, Volume 698, Issue 1-3, pp. 404 - 412
Journal Article
Immunity, ISSN 1074-7613, 01/2011, Volume 34, Issue 1, pp. 61 - 74
Erythropoietin (EPO) is the principal cytokine regulating erythropoiesis through its receptor, EPOR. Interestingly, EPORs are also found on immune cells with... 
ISCHEMIA-REPERFUSION INJURY | INFLAMMATORY-BOWEL-DISEASE | BRAIN-INJURY | RECOMBINANT-HUMAN-ERYTHROPOIETIN | NITRIC-OXIDE SYNTHASE | IN-VIVO | CARBAMYLATED ERYTHROPOIETIN | IRON | MICE | ANEMIA | IMMUNOLOGY | Tumor Necrosis Factor-alpha - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Macrophages, Peritoneal - pathology | Salmonella Infections - immunology | Male | NF-kappa B - metabolism | Salmonella - pathogenicity | Receptors, Erythropoietin - genetics | Signal Transduction - immunology | Colitis - chemically induced | Inflammation Mediators - metabolism | Tumor Necrosis Factor-alpha - immunology | Colitis - drug therapy | Colitis - immunology | Macrophages, Peritoneal - drug effects | Cell Line | Erythropoietin - administration & dosage | Nitric Oxide - immunology | Salmonella Infections - drug therapy | Mice, Inbred C57BL | Trinitrobenzenesulfonic Acid - administration & dosage | Macrophages, Peritoneal - immunology | Signal Transduction - genetics | Mice, Knockout | Salmonella - immunology | Animals | Signal Transduction - drug effects | Mice | Dextran Sulfate - administration & dosage | Macrophages, Peritoneal - metabolism | Nitric Oxide - metabolism | Receptors, Erythropoietin - metabolism | Index Medicus | Erythropoiesis | Pathogens | Cytokines | Erythropoietin | Immunomodulation | Inflammation | Macrophages | Inflammatory diseases | Nitric-oxide synthase | Infection | Cell activation | Nitric oxide | Colitis | Tumor necrosis factor- alpha
Journal Article